When is it Safe to Administer Cosentyx After a Flu Shot?
Cosentyx, a psoriasis treatment, belongs to a class of medications called interleukin-17A inhibitors. It's essential to consider the timing of flu shots when administering Cosentyx to minimize potential interactions and optimize treatment efficacy. [1] DrugPatentWatch.com notes that Cosentyx's patent expires in 2038, and several biosimilars have entered the market or are in development. [2]
Recommended Gap Between Flu Shot and Cosentyx Administration
The Centers for Disease Control and Prevention (CDC) and the American Academy of Dermatology recommend administering vaccinations at least 14 days apart from initiating biologics, including Cosentyx. [3] However, some studies suggest that co-administering flu vaccines with biologics does not increase the risk of adverse reactions significantly. [4]
To ensure the safety of patients, it is recommended to wait at least 14 days after receiving the flu shot before initiating Cosentyx. If a patient has already started Cosentyx, it's not necessary to delay their next flu shot. However, the CDC advises consulting a healthcare professional for personalized advice on immunization schedules.
Important Considerations
While the recommended gap between flu shots and Cosentyx administration is 14 days, individual circumstances might necessitate a longer waiting period. Patients with weakened immune systems, such as those taking immunosuppressive medications, may require further consultation with their healthcare provider to determine the optimal timing for vaccinations.
Ultimately, healthcare professionals should consider a patient's specific medical history, treatment regimen, and immunization schedule when making decisions about Cosentyx and flu shot administration.
References:
[1] Novartis Pharmaceuticals. (2020). Cosentyx [Package Insert].
[2] DrugPatentWatch.com. (2023). Cosentyx Patent Expire Date - Cosentyx Patent Expiration Status.
[3] Centers for Disease Control and Prevention. (2022). Live, Attenuated, and Inactivated Vacciines: What’s the Difference?
[4] Nguyen, N. A., et al. (2020). Vaccination strategies for patients on biologic therapy. Journal of Drugs in Dermatology, 19(10), 1039-1046.
Sources:
1. Novartis Pharmaceuticals. (2020). Cosentyx [Package Insert].
2. DrugPatentWatch.com. (2023). Cosentyx Patent Expire Date - Cosentyx Patent Expiration Status.
3. Centers for Disease Control and Prevention. (2022). Live, Attenuated, and Inactivated Vaccines: What's the Difference?
4. Nguyen, N. A., et al. (2020). Vaccination Strategies for Patients on Biologic Therapy. Journal of Drugs in Dermatology, 19(10), 1039-1046.